1. Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection

   • Leanne Embree
   • Karen Gelmon
   • Lawrence D. Mayer

   ORIGINAL ARTICLE Pages: 347 - 352

2. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line

   • Young Sook Son
   • Jae Myoung Suh
   • Mark T. Muller

   ORIGINAL ARTICLE Pages: 353 - 360

3. Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line

   • D. A. Gewirtz
   • Joyce K. Randolph
   • Frank A. Fornari

   ORIGINAL ARTICLE Pages: 361 - 369

4. Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat model

   • Kamelia Behnia
   • Mehdi Boroujerdi

   ORIGINAL ARTICLE Pages: 370 - 376

5. A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study

   • O. van Tellingen
   • C. J. A. Punt
   • J. H. Beijnen

   ORIGINAL ARTICLE Pages: 377 - 384

6. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems

   • Simona Romanelli
   • Paola Perego
   • Franco Zunino

   ORIGINAL ARTICLE Pages: 385 - 390

7. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells

   • Joanna M. Watson
   • David G. I. Kingston
   • J. Stephen Haskill

   ORIGINAL ARTICLE Pages: 391 - 397

8. The mechanism of polyamine analog-induced enhancement of cisplatin cytotoxicity in the U-251 MG human malignant glioma cell line

   • Jonathan Paliwal
   • Gita Janumpalli
   • Hirak S. Basu

   ORIGINAL ARTICLE Pages: 398 - 402

9. Gemcitabine induces programmed cell death and activates protein kinase C in BG-1 human ovarian cancer cells

   • Leanne Cartee
   • Gregory Louis Kucera

   ORIGINAL ARTICLE Pages: 403 - 412

10. Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation

    • Fergus R. MacLean
    • Roderick Skinner
    • Andrew D. J. Pearson

    SHORT COMMUNICATION Pages: 413 - 416

11. Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphorase

    • Valerie G. Brunton
    • Gregor Steele
    • P. Workman

    SHORT COMMUNICATION Pages: 417 - 422

12. Effect of filgrastim on the pharmacokinetics of MX2 hydrochloride in patients with advanced malignant disease

    • Denis J. Morgan
    • John S. Hill
    • Michael D. Green

    SHORT COMMUNICATION Pages: 423 - 426

13. Progression of Parkinson's disease with impairment of vision under carboplatin /cyclophosphamide therapy for ovarian cancer

    • M. Linn
    • E. Brodt
    • Martin Kolben

    SHORT COMMUNICATION Pages: 427 - 428